LAUREN SHIELDS: Open Payments
NPI 1417572975 · BEND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,448 in 59 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,448
Food & beverage: $1,348Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $429 |
| ABBVIE INC. | 12 | $313 |
| GENZYME CORPORATION | 12 | $279 |
| Lilly USA, LLC | 9 | $250 |
| Galderma Laboratories, L.P. | 2 | $128 |
| Incyte Corporation | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
Products named: TREMFYA, DUPIXENT, RINVOQ, NEMLUVIO, EBGLYSS, TALTZ, SKYRIZI, Opzelura.
Industry payments across OR — which companies pay providers there.
